Molecular Simulations and Drug Discovery of Adenosine Receptors

Molecules. 2022 Mar 22;27(7):2054. doi: 10.3390/molecules27072054.

Abstract

G protein-coupled receptors (GPCRs) represent the largest family of human membrane proteins. Four subtypes of adenosine receptors (ARs), the A1AR, A2AAR, A2BAR and A3AR, each with a unique pharmacological profile and distribution within the tissues in the human body, mediate many physiological functions and serve as critical drug targets for treating numerous human diseases including cancer, neuropathic pain, cardiac ischemia, stroke and diabetes. The A1AR and A3AR preferentially couple to the Gi/o proteins, while the A2AAR and A2BAR prefer coupling to the Gs proteins. Adenosine receptors were the first subclass of GPCRs that had experimental structures determined in complex with distinct G proteins. Here, we will review recent studies in molecular simulations and computer-aided drug discovery of the adenosine receptors and also highlight their future research opportunities.

Keywords: G protein-coupled receptors; adenosine receptors; drug discovery; mechanisms; molecular simulations.

Publication types

  • Review

MeSH terms

  • Drug Discovery
  • GTP-Binding Proteins* / metabolism
  • Humans
  • Receptors, Purinergic P1* / chemistry

Substances

  • Receptors, Purinergic P1
  • GTP-Binding Proteins